ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,524, issued on Oct. 14, was assigned to Western Sydney Local Health District (Sydney) and The Wetmead Institute for Medical Research (Sydney).
"Bacteriophage treatment and reduction in inflammatory response" was invented by Ching Yu Lin (Marina Del Rey, Calif.) and Jonathan Ripley Iredell (Marina Del Rey, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the treatment of bacterial infections and the reduction of inflammatory response using bacteriophage compositions. In an aspect, provided herein are methods of treating a bacterial infection characterized by inflammation in a subject, the method comprising admini...